echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetes Care: Serum magnesium is negatively correlated with heart failure, atrial fibrillation and microvascular complications in patients with type 2 diabetes

    Diabetes Care: Serum magnesium is negatively correlated with heart failure, atrial fibrillation and microvascular complications in patients with type 2 diabetes

    • Last Update: 2021-07-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, a research article published in Diabetes Care, an authoritative journal in the field of diabetes , researchers aimed to investigate whether there is a prospective correlation between serum magnesium (Mg2+) in patients with type 2 diabetes (T2D) and macrovascular or microvascular complications.


    Diabetic blood vessels

    Researchers used Cox regression to analyze the relationship between serum Mg2+ and macrovascular disease and mortality (acute myocardial infarction [AMI], coronary heart disease [CHD], heart failure [HF], cerebrovascular accident [CVA] and peripheral artery disease in 4348 participants.


    Myocardial infarction



    During the 5.




    Serum Mg2+ concentration is negatively correlated with the risk of HF and AF, as well as the occurrence of CKD, diabetic retinopathy and T2D foot complications
    .
    Blood glucose control partially mediates the association between serum Mg2+ and HF and microvascular complications
    .
    Original Source: Serum Magnesium Is is Inversely Associated With Heart Failure, Atrial Fibrillation, and Microvascular Complications in Type 2 Diabetes in this message





    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.